BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10698336)

  • 1. How are immune complexes bound to the primate erythrocyte complement receptor transferred to acceptor phagocytic cells?
    Nardin A; Lindorfer MA; Taylor RP
    Mol Immunol; 1999; 36(13-14):827-35. PubMed ID: 10698336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Processing of C3b-opsonized immune complexes bound to non-complement receptor 1 (CR1) sites on red cells: phagocytosis, transfer, and associations with CR1.
    Craig ML; Waitumbi JN; Taylor RP
    J Immunol; 2005 Mar; 174(5):3059-66. PubMed ID: 15728520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfer of immune complexes from erythrocyte CR1 to mouse macrophages.
    Reinagel ML; Taylor RP
    J Immunol; 2000 Feb; 164(4):1977-85. PubMed ID: 10657648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune complexes bound to the primate erythrocyte complement receptor (CR1) via anti-CR1 mAbs are cleared simultaneously with loss of CR1 in a concerted reaction in a rhesus monkey model.
    Taylor RP; Ferguson PJ; Martin EN; Cooke J; Greene KL; Grinspun K; Guttman M; Kuhn S
    Clin Immunol Immunopathol; 1997 Jan; 82(1):49-59. PubMed ID: 9000042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prototype pathogen bound ex vivo to human erythrocyte complement receptor 1 via bispecific monoclonal antibody complexes is cleared to the liver in a mouse model.
    Nardin A; Schlimgen R; Holers VM; Taylor RP
    Eur J Immunol; 1999 May; 29(5):1581-6. PubMed ID: 10359112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heteropolymer-mediated clearance of immune complexes via erythrocyte CR1: mechanisms and applications.
    Lindorfer MA; Hahn CS; Foley PL; Taylor RP
    Immunol Rev; 2001 Oct; 183():10-24. PubMed ID: 11782244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clearance of anti-double-stranded DNA antibodies: the natural immune complex clearance mechanism.
    Craig ML; Bankovich AJ; McElhenny JL; Taylor RP
    Arthritis Rheum; 2000 Oct; 43(10):2265-75. PubMed ID: 11037886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concerted clearance of immune complexes bound to the human erythrocyte complement receptor: development of a heterologous mouse model.
    Henderson AL; Lindorfer MA; Kennedy AD; Foley PL; Taylor RP
    J Immunol Methods; 2002 Dec; 270(2):183-97. PubMed ID: 12379324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visualization of the transfer reaction: tracking immune complexes from erythrocyte complement receptor 1 to macrophages.
    Craig ML; Bankovich AJ; Taylor RP
    Clin Immunol; 2002 Oct; 105(1):36-47. PubMed ID: 12483992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of model immune complexes to erythrocyte CR1 facilitates immune complex uptake by U937 cells.
    Emlen W; Burdick G; Carl V; Lachmann PJ
    J Immunol; 1989 Jun; 142(12):4366-71. PubMed ID: 2524529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of complement receptor type 1 (CR1, CD35) in determining the cellular distribution of opsonized immune complexes between whole blood cells: kinetic analysis of the buffering capacity of erythrocytes.
    Nielsen CH; Matthiesen SH; Lyng I; Leslie RG
    Immunology; 1997 Jan; 90(1):129-37. PubMed ID: 9038723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional characterization of non-human primate erythrocyte immune adherence receptors: implications for the uptake of immune complexes by the cells of the mononuclear phagocytic system.
    Edberg JC; Kimberly RP; Taylor RP
    Eur J Immunol; 1992 Jun; 22(6):1333-9. PubMed ID: 1376254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing the endocytosis of immune complexes.
    van Es LA; Daha MR
    Adv Nephrol Necker Hosp; 1984; 13():341-67. PubMed ID: 6236677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Staphylococcus aureus bound to complement receptor 1 on human erythrocytes by bispecific monoclonal antibodies is phagocytosed by acceptor macrophages.
    Gyimesi E; Bankovich AJ; Schuman TA; Goldberg JB; Lindorfer MA; Taylor RP
    Immunol Lett; 2004 Sep; 95(2):185-92. PubMed ID: 15388259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Erythrocyte CR1 receptor: binding and transport of immune complexes in the blood circulation].
    Pascual M; Schifferli JA
    Schweiz Med Wochenschr; 1993 Jan; 123(3):39-43. PubMed ID: 8426946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between immune complex binding and release and the quantitative expression of the complement receptor, type 1 (CR1, CD35) on human erythrocytes.
    Gibson NC; Waxman FJ
    Clin Immunol Immunopathol; 1994 Feb; 70(2):104-13. PubMed ID: 8299225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B cell complement receptor 2 transfer reaction.
    Lindorfer MA; Jinivizian HB; Foley PL; Kennedy AD; Solga MD; Taylor RP
    J Immunol; 2003 Apr; 170(7):3671-8. PubMed ID: 12646632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primate erythrocyte (E) complement receptor (CR1) as an anchor site for bispecific-based therapies to clear pathogens or autoantibodies safely from the circulation.
    Taylor RP; Ferguson PJ
    J Hematother; 1995 Oct; 4(5):357-62. PubMed ID: 8581369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement coating of erythrocytes is reduced following their interaction with neutrophils in vitro without loss of complement receptor 1 (CR1).
    Imrie HJ; Jones DR
    Clin Exp Immunol; 1997 Jul; 109(1):217-22. PubMed ID: 9218847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Another function of erythrocytes: transport of circulating immune complexes.
    Pascual M; Schifferli JA
    Infusionsther Transfusionsmed; 1995 Oct; 22(5):310-5. PubMed ID: 8924746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.